Satoshi Kokubo Selected Research

cimadronate

9/2004	Effect of incadronate on corticosteroid-induced osteopenia in rats.
12/2002	Incadronate inhibits osteoporosis in ovariectomized rats.
8/2002	Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Kokubo Research Topics

Disease

2	Urinary Tract Infections (Urinary Tract Infection) 04/2017 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 04/2017 - 01/2016
2	Inflammation (Inflammations) 01/2012 - 09/2006
2	Convalescence 05/2010 - 06/2002
2	Bone Resorption 12/2002 - 08/2002
1	Rheumatoid Arthritis 05/2022
1	Ruptured Aneurysm 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Body Weight (Weight, Body) 04/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016
1	Fibrosis (Cirrhosis) 01/2012
1	Necrosis 01/2012
1	Peritoneal Fibrosis 01/2012
1	Acute Kidney Injury (Acute Renal Failure) 01/2012
1	Bone Diseases (Bone Disease) 01/2007
1	Diabetes Mellitus 01/2007
1	Hypoparathyroidism 01/2007
1	Reperfusion Injury 09/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2005
1	Metabolic Bone Diseases (Osteopenia) 09/2004
1	Neoplasm Metastasis (Metastasis) 12/2002
1	Osteoporosis 12/2002
1	Hypercalcemia (Milk Alkali Syndrome) 12/2002
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 06/2002
1	Glomerulonephritis 06/2002

Drug/Important Bio-Agent (IBA)

3	cimadronateIBA 09/2004 - 08/2002
2	Metformin (Glucophage)FDA LinkGeneric 04/2017 - 01/2016
2	ipragliflozinIBA 04/2017 - 01/2016
2	ChemokinesIBA 01/2012 - 09/2006
2	p38 Mitogen-Activated Protein KinasesIBA 01/2012 - 06/2002
2	GlucocorticoidsIBA 05/2010 - 06/2002
1	Antirheumatic Agents (DMARD)IBA 05/2022
1	Janus Kinase InhibitorsIBA 05/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2017
1	Glucose (Dextrose)FDA LinkGeneric 04/2017
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2012
1	FR 167653IBA 01/2012
1	AntibodiesIBA 01/2012
1	Chemotactic FactorsIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	CytokinesIBA 01/2012
1	Chemokine ReceptorsIBA 01/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2012
1	Fas Ligand Protein (Fas Ligand)IBA 01/2012
1	Parathyroid Hormone (Parathormone)IBA 01/2007
1	Sevelamer (RenaGel)FDA Link 01/2007
1	Phosphates (Orthophosphate)IBA 01/2007
1	Calcium Carbonate (Limestone)FDA Link 01/2007
1	CalciumIBA 01/2007
1	Vitamin D FDA LinkGeneric 01/2007
1	Therapeutic UsesIBA 01/2007
1	A-factor (Streptomyces)IBA 09/2006
1	InterleukinsIBA 09/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	N 30IBA 01/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2005
1	Diphosphonates (Bisphosphonates)IBA 09/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2004
1	Pharmaceutical PreparationsIBA 12/2002
1	NF-kappa B (NF-kB)IBA 06/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2002
1	Aftercare (After-Treatment) 04/2017
1	Glycemic Control 01/2016
1	Peritoneal Dialysis 01/2012
1	Renal Dialysis (Hemodialysis) 01/2007